ESAB Cuts 2026 Guidance: Core Adjusted EPS to $5.28-$5.33, EBITDA to $603M-$607M
ESAB sits 21% above its 52-week low of $62.74.
Summary
ESAB posted record Q3 sales of $825M and a 19.8% core adjusted EBITDA margin, but cut full-year core adjusted EPS guidance to $5.28-$5.33 and EBITDA to $603M-$607M as core organic growth slowed to 1.6%-2.0%.
Key Events · Earnings and Guidance · ESAB
-
Q3 Sales Hit Record $825M
Net sales rose 13.3% to $824.5M from $727.8M, with core organic sales up 2.3% and acquisitions adding 11.3% of core growth.
-
Full-Year Guidance Cut
2026 core adjusted EBITDA guidance lowered to $603M-$607M from $615M-$625M; core adjusted EPS to $5.28-$5.33 from $5.40-$5.50; core organic growth to 1.6%-2.0% from 2.0%-4.0%.
-
Margins Expand on EBXai
Core adjusted EBITDA of $156.1M rose 17.0% and margin expanded 40 basis points to 19.8% from 19.4%.
-
GAAP Profit and Cash Flow Slip
Net income attributable to ESAB fell to $38.9M from $54.8M on interest expense of $36.5M versus $23.6M; adjusted free cash flow was $60.0M versus $86.4M.
Analysis · ESAB · Technology
The headline numbers looked strong, but the full-year outlook came down. Record third-quarter sales of $825M (up 13.3%) and core adjusted EBITDA of $156M (up 17.0%, 19.8% margin) were solid, yet core adjusted EBITDA guidance drops to $603M-$607M from $615M-$625M and core adjusted EPS to $5.28-$5.33 from $5.40-$5.50, with core organic growth now 1.6%-2.0% versus 2.0%-4.0% before. The shortfall is organic, not acquisition-driven: M&A contribution was actually raised to about 9.5% and FX to about 2.0%, so the total sales range narrowed to 13.1%-13.3% only because underlying demand is softer. GAAP net income fell to $38.9M from $54.8M a year ago on higher interest expense ($36.5M vs $23.6M) and acquisition amortization, and adjusted free cash flow slipped to $60.0M from $86.4M.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ESAB was trading at $76.04 on NYSE in the Technology sector, with a market capitalization of approximately $4.7B. The 52-week trading range was $62.74 to $137.42. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.